期刊文献+

冠心病患者甲状腺激素水平与血脂的相关性 被引量:2

Relevance between serum thyroid hormone levels and lipid profile in patients with coronary heart disease
原文传递
导出
摘要 目的:探讨甲状腺激素正常的冠心病患者中甲状腺激素与血脂的相关性。方法:选取我院117例冠心病患者,测定血清三碘甲状腺原氨酸(TT3)、甲状腺素(TT4)、游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)、促甲状腺素(TSH)、三酰甘油(TG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、载脂蛋白A1(apoA1)、载脂蛋白B(apoB)的水平。结果:男性组FT4与apoA1呈显著正相关(r=0.238,P<0.05);女性组TSH与apoA1呈显著负相关(r=-0.308,P<0.05)。结论:在甲状腺功能正常的冠心病患者中,甲状腺激素与血脂之间有一定的相关性。对甲状腺激素水平低的患者更应积极预防其并发心力衰竭。 Objective:To investigate the relevance between serum thyroid hormone levels and lipid profile in euthyroid patients with coronary heart disease(CHD).Methods: 117 patients with CHD were enrolled.The serum concentrations of TT3,TT4,FT3,FT4,TSH,TG,TC,HDL-C,LDL-C,apoA1 and apoB were measured.Results: The levels of FT4 in male group were significantly positively correlated with levels of apoA 1(r=0.238,P0.05);the levels of TSH in female group were significantly negatively correlated with the levels of apoA1(r=-0.308,P0.05).Conclusion: There were correlation between certain parameters of serum thyroid hormone levels and lipid profile in euthyroid patients with CHD.The thyroid hormone should be given more attention to prevent concurrent heart failure in patients with low thyroid hormone levels.
机构地区 航天中心医院
出处 《中国卫生检验杂志》 北大核心 2012年第11期2691-2692,共2页 Chinese Journal of Health Laboratory Technology
关键词 冠心病 甲状腺激素 血脂 Coronary heart disease Thyroid hormone Serum lipids
  • 相关文献

参考文献9

  • 1Maim J. Thyroid Hormone Ligands and Metabolic Diseases [ J ]. Curr Pharm Des,2004,10 ( 28 ) :3525 - 3532.
  • 2Liu YY, Brent GA. Thyroid hormone crosstalk with nuclear receptor signaling in metabolic regulation[ J]. Trends Endocrinol Metab,2010. 21(3) :166 -173.
  • 3Oetting A, Yen PM. New insights into thyroid hormone action [ J ]. Best Pract Res Clin Endocrinol Metab,2007,21 (2) :195 208.
  • 4汪莉,高天,汪海娅.老年单纯收缩期高血压合并高脂血症肱动脉内皮功能研究[J].上海交通大学学报(医学版),2008,28(5):512-515. 被引量:10
  • 5Romney JS, Chan J, Cart FE, et al. Identification of the thyroid hormone -responsive messenger RNA spot 11 as apolipoprotein - AI mes- senger RNA and effects of the hormone on the promoter[J]. Mol Endocrinol, 1992, 6(6) :943 -950.
  • 6Taylor AH, Wishart P, Lawless DE, et al. Identification of functional positive and negative thyroid hormone - responsive elements in the rat apoli- poprotein AI promoter [ J ]. Biochemistry, 1996, 35 ( 25 ) :8281 - 8288.
  • 7石玛丽 孙玲.冠心病患者FT3、rT3变化的临床意义[J].中国实用内科杂志,1994,14:678-678.
  • 8谭丽娟,林淑美,王相勋,毛拥军,王卫红.老年冠心病病人血清甲状腺激素与血脂水平的检测[J].青岛大学医学院学报,2003,39(3):315-316. 被引量:6
  • 9Grover GJ, Mellstrtim K, Ye L, et al. Selective thyroid hormone re- ceptor - beta activation: a strategy for reduction of weight, cholesterol, and lipoprotein ( a ) with reduced cardiovascular liability [ J ]. Proc Natl Acad Sci U S A, 2003, 100(17) :10067 - 10072.

二级参考文献18

  • 1石玛丽 孙玲.冠心病患者FT3、rT3变化的临床意义[J].中国实用内科杂志,1994,14:678-678.
  • 2Sauter G Weiss M Hoermann R.Cholesterol 7α-hydroxylase activity in hypothyroidism in human[J].Horm Metab Res,1997,29(4):177-177.
  • 3Laurent S, Boutouyrie P. Arterial stiffness: a new surrogate end point for cardiovascular disease [ J ] ? J Nephrol, 2007,20 ( suppl 12) : S45 -S50.
  • 4Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [ J ]. Hypertension,2003, 42 (6) : 1206 - 1252.
  • 5Maas R, Scllwedhelm E, Kahl L, et al. Simultaneous assessment of endothelial function, nitric oxide synthase activity, nitric oxide mediated signaling, and oxidative stress in individuals with and without hypercholesterolemia [ J ]. Clin Chem,2008,54 ( 2 ) :292 - 300.
  • 6John S, Schmieder RE. Potential mechanisms of impaired endothelial function in arterial hypertension and hypercholesterolemia [J]. Curt Hypertens Rep, 2003, 5(3):199-207.
  • 7Caballero AE, Arora S, Saouaf R, et al. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes [ J ]. Diabetes, 1999,48 (9) : 1856 - 1862.
  • 8Schroeder S, Enderle MD, Ossen R, et al. Noninvasive determination of endothelium-mediated vasodilation as a screening test for coronary artery disease: pilot study to assess the predictive value in comparison with angina pectoris, exercise electrocardiography, and myocardial perfusion imaging [ J ]. Am Heart J, 1999,138 (4 pt 1 ) : 731 - 739.
  • 9Celermajer DS,Sorensen KE,Bull C, et al. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction [ J]. J Am Coil Cardiol, 1994,24(6) : 1468 - 1474.
  • 10Benjamin EJ, Larson MG, Keyes M J, et al. Clinical correlates and heritability of flow-mediated dilation in the community : The Framingham Heart Study[J]. Circulation, 2004, 109(5) :613 -619.

共引文献18

同被引文献15

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部